Distinct dynamics of antigen-specific induction and differentiation of different CD11c+Tbet+ B-cell subsets

J Allergy Clin Immunol. 2023 Sep;152(3):689-699.e6. doi: 10.1016/j.jaci.2023.02.020. Epub 2023 Feb 27.

Abstract

Background: CD11c+Tbet+ B cells are enriched in autoimmunity and chronic infections and also expand on immune challenge in healthy individuals. CD11c+Tbet+ B cells remain an enigmatic B-cell population because of their intrinsic heterogeneity.

Objectives: We investigated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen-specific development and differentiation properties of 3 separate CD11c+ B-cell subsets-age-associated B cells (ABCs), double-negative 2 (DN2) B cells, and activated naive B cells-and compared them to their canonical CD11c- counterparts.

Methods: Dynamics of the response of the 3 CD11c+ B-cell subsets were assessed at SARS-CoV-2 vaccination in healthy donors by spectral flow cytometry. Distinct CD11c+ B-cell subsets were functionally characterized by optimized in vitro cultures.

Results: In contrast to a durable expansion of antigen-specific CD11c- memory B cells over time, both ABCs and DN2 cells were strongly expanded shortly after second vaccination and subsequently contracted. Functional characterization of antibody-secreting cell differentiation dynamics revealed that CD11c+Tbet+ B cells were primed for antibody-secreting cell differentiation compared to relevant canonical CD11c- counterparts.

Conclusion: Overall, CD11c+Tbet+ B cells encompass heterogeneous subpopulations, of which primarily ABCs as well as DN2 B cells respond early to immune challenge and display a pre-antibody-secreting cell phenotype.

Keywords: CD11c(+)Tbet(+) atypical B cell; SARS-CoV-2 vaccination; activated naive; age-associated B cell; antibody-secreting cell differentiation; double negative 2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocyte Subsets*
  • COVID-19 Vaccines
  • COVID-19*
  • Cell Differentiation
  • Humans
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines